BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Higuchi T, Abe M, Yamazaki T, Okawa E, Ando H, Hotta S, Oikawa O, Kikuchi F, Okada K, Soma M. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial. Am J Kidney Dis 2016;67:260-70. [PMID: 26508680 DOI: 10.1053/j.ajkd.2015.09.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Abe M, Higuchi T, Moriuchi M, Okamura M, Tei R, Nagura C, Takashima H, Kikuchi F, Tomita H, Okada K. Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trial. Diabetes Research and Clinical Practice 2016;116:244-52. [DOI: 10.1016/j.diabres.2016.04.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
2 Kamei Y, Kamei D, Tsuchiya K, Mineshima M, Nitta K. Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients. PLoS One 2018;13:e0201591. [PMID: 30133480 DOI: 10.1371/journal.pone.0201591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ueno Y, Saito A, Nakata J, Kamagata K, Taniguchi D, Motoi Y, Io H, Andica C, Shindo A, Shiina K, Miyamoto N, Yamashiro K, Urabe T, Suzuki Y, Aoki S, Hattori N. Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients. Nutrients 2021;13:1292. [PMID: 33919810 DOI: 10.3390/nu13041292] [Reference Citation Analysis]
4 Suzuki A, Sakai Y, Hashimoto K, Osawa H, Tsuruoka S. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients. Ren Fail 2018;40:196-200. [PMID: 29616582 DOI: 10.1080/0886022X.2018.1455587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
5 Huang Y, Wang S, Zhou J, Liu Y, Du C, Yang K, Bi X, Liu M, Han W, Wang K, Xiong J, Wang S, Wang Y, Nie L, Liu C, Zhang D, Gu J, Zeng C, Zhao J. IRF1-mediated downregulation of PGC1α contributes to cardiorenal syndrome type 4. Nat Commun 2020;11:4664. [PMID: 32938919 DOI: 10.1038/s41467-020-18519-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Maki KC, Wilcox ML, Dicklin MR, Kakkar R, Davidson MH. Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis. BMC Nephrol 2022;23:34. [PMID: 35034619 DOI: 10.1186/s12882-022-02666-1] [Reference Citation Analysis]
7 Sgambat K, Clauss S, Moudgil A. Effect of levocarnitine supplementation on myocardial strain in children with acute kidney injury receiving continuous kidney replacement therapy: a pilot study. Pediatr Nephrol 2021;36:1607-16. [PMID: 33389092 DOI: 10.1007/s00467-020-04862-3] [Reference Citation Analysis]
8 Askarpour M, Hadi A, Symonds ME, Miraghajani M, Omid Sadeghi, Sheikhi A, Ghaedi E. Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials. Nutrition, Metabolism and Cardiovascular Diseases 2019;29:1151-67. [DOI: 10.1016/j.numecd.2019.07.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
9 Daimon S, Yasuda M, Nishitani M. Serum carnitine concentration and the acyl to free carnitine ratio in nondialysis chronic kidney disease and hemodialysis patients. Ther Apher Dial 2022;26:122-9. [PMID: 33656789 DOI: 10.1111/1744-9987.13638] [Reference Citation Analysis]
10 Maruyama T, Higuchi T, Yamazaki T, Okawa E, Ando H, Oikawa O, Inoshita A, Okada K, Abe M. Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia. Cardiorenal Med 2017;7:188-97. [PMID: 28736559 DOI: 10.1159/000462983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
11 Lunney M, Ruospo M, Natale P, Quinn RR, Ronksley PE, Konstantinidis I, Palmer SC, Tonelli M, Strippoli GF, Ravani P. Pharmacological interventions for heart failure in people with chronic kidney disease. Cochrane Database Syst Rev 2020;2:CD012466. [PMID: 32103487 DOI: 10.1002/14651858.CD012466.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Blanca AJ, Ruiz-armenta MV, Zambrano S, Miguel-carrasco JL, González-roncero FM, Fortuño A, Revilla E, Mate A, Vázquez CM. l -Carnitine ameliorates the oxidative stress response to angiotensin II by modulating NADPH oxidase through a reduction in protein kinase c activity and NF-κB translocation to the nucleus. Food Chemistry 2017;228:356-66. [DOI: 10.1016/j.foodchem.2017.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Askarpour M, Hadi A, Dehghani Kari Bozorg A, Sadeghi O, Sheikhi A, Kazemi M, Ghaedi E. Effects of l-carnitine supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Hum Hypertens 2019;33:725-34. [DOI: 10.1038/s41371-019-0248-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sherman RA. Briefly Noted. Semin Dial 2016;29:417-8. [DOI: 10.1111/sdi.12519] [Reference Citation Analysis]
15 Maruyama N, Otsuki T, Yoshida Y, Nagura C, Kitai M, Shibahara N, Tomita H, Maruyama T, Abe M. Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients. Am J Nephrol 2018;47:406-14. [PMID: 29874654 DOI: 10.1159/000489964] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
16 Maruyama T, Maruyama N, Higuchi T, Nagura C, Takashima H, Kitai M, Utsunomiya K, Tei R, Furukawa T, Yamazaki T, Okawa E, Ando H, Kikuchi F, Abe M. Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial. Eur J Clin Nutr 2019;73:293-301. [PMID: 30353121 DOI: 10.1038/s41430-018-0348-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Takashima H, Maruyama T, Abe M. Significance of Levocarnitine Treatment in Dialysis Patients. Nutrients 2021;13:1219. [PMID: 33917145 DOI: 10.3390/nu13041219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Marshall MR, Vandal AC, de Zoysa JR, Gabriel RS, Haloob IA, Hood CJ, Irvine JH, Matheson PJ, McGregor DOR, Rabindranath KS, Schollum JBW, Semple DJ, Xie Z, Ma TM, Sisk R, Dunlop JL. Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial. J Am Soc Nephrol 2020;31:1078-91. [PMID: 32188697 DOI: 10.1681/ASN.2019090877] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
19 Shimizu S, Takashima H, Tei R, Furukawa T, Okamura M, Kitai M, Nagura C, Maruyama T, Higuchi T, Abe M. Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Peritoneal Dialysis. Nutrients 2019;11:E2645. [PMID: 31689941 DOI: 10.3390/nu11112645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
20 Bazargani B, Mojtahedi SY, Fahimi D, Askarian F, Moghtaderi M, Abbasi A, Samimi M, Bakhtiari Koohsorkhi M. Evaluation of the relationship between serum carnitine levels and intradialytic complications in children with kidney failure. Pediatr Nephrol 2022. [PMID: 35118545 DOI: 10.1007/s00467-022-05449-w] [Reference Citation Analysis]
21 Morgans HA, Chadha V, Warady BA. The role of carnitine in maintenance dialysis therapy. Pediatr Nephrol 2021;36:2545-51. [PMID: 34143302 DOI: 10.1007/s00467-021-05101-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kaneko M, Fukasawa H, Ishibuchi K, Niwa H, Yasuda H, Furuya R. L-carnitine Improved the Cardiac Function via the Effect on Myocardial Fatty Acid Metabolism in a Hemodialysis Patient. Intern Med 2018;57:3593-6. [PMID: 30146554 DOI: 10.2169/internalmedicine.1055-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
23 Zhu Y, Xue C, Ou J, Xie Z, Deng J. Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis. Int Urol Nephrol 2021. [PMID: 33713287 DOI: 10.1007/s11255-021-02835-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sherman RA. Briefly Noted. Semin Dial 2016;29:521-2. [DOI: 10.1111/sdi.12546] [Reference Citation Analysis]
25 Raeisi-Dehkordi H, Muka T. Meta-analysis of l-carnitine supplementation on lipid profile and glycemic control: Inadequate search strategy and other methodological issues. Clin Nutr 2020;39:1975-6. [PMID: 32386858 DOI: 10.1016/j.clnu.2020.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Sugiyama M, Hazama T, Nakano K, Urae K, Moriyama T, Ariyoshi T, Kurokawa Y, Kodama G, Wada Y, Yano J, Otsubo Y, Iwatani R, Kinoshita Y, Kaida Y, Nasu M, Shibata R, Tashiro K, Fukami K. Effects of Reducing L-Carnitine Supplementation on Carnitine Kinetics and Cardiac Function in Hemodialysis Patients: A Multicenter, Single-Blind, Placebo-Controlled, Randomized Clinical Trial. Nutrients 2021;13:1900. [PMID: 34073024 DOI: 10.3390/nu13061900] [Reference Citation Analysis]
27 Maruyama T, Abe M. Effects of Levocarnitine Treatment on the Cardiac Function in Hemodialysis Patients. Intern Med 2018;57:3503-5. [PMID: 30146610 DOI: 10.2169/internalmedicine.1575-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Kumagai E, Hosohata K, Furumachi K, Takai S. Effectiveness of monitoring free carnitine levels for L-carnitine supplementation in hemodialysis patients to maintain carnitine sufficiency and nutritional factors. Ther Apher Dial 2021;25:595-606. [PMID: 33470531 DOI: 10.1111/1744-9987.13621] [Reference Citation Analysis]